Status:

COMPLETED

Assessment of the Effects of Access Count in Percutaneous Nephrolithotomy on Renal Functions by Technetium-99M-Dimercaptosuccinic Acid Scintigraphy

Lead Sponsor:

TC Erciyes University

Conditions:

Renal Parenchymal Loss After the Percutaneous Nephrolithotomy

Eligibility:

All Genders

20-60 years

Phase:

NA

Brief Summary

In this study 37 patients who had undergone percutaneous nephrolithotomy were included. Preoperative DMSA scans were performed a day before the surgery, whereas postoperative scans were randomized by ...

Detailed Description

Total 37 patients who had undergone PCNL were included between June 2007-June 2009. All patients were evaluated routinely with physical examination, complete blood count (CBC), blood urine nitrogen (B...

Eligibility Criteria

Inclusion

  • \- Patients with renal stones which was bigger than 2cm.

Exclusion

  • Patients with acute urinary tract infection,
  • Patients with bleeding disorder,
  • Patients with chronic renal failure,
  • Patients with solitary kidney, renal ectopy or history of any other urinary abnormality.

Key Trial Info

Start Date :

June 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

37 Patients enrolled

Trial Details

Trial ID

NCT01819753

Start Date

June 1 2007

End Date

June 1 2009

Last Update

March 28 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Erciyes University Faculty of Medicine.

Kayseri, Turkey (Türkiye), 38039

Assessment of the Effects of Access Count in Percutaneous Nephrolithotomy on Renal Functions by Technetium-99M-Dimercaptosuccinic Acid Scintigraphy | DecenTrialz